LOCOREGIONALLY ADVANCED NASOPHARYNGEAL CARCINOMA
Clinical trials for LOCOREGIONALLY ADVANCED NASOPHARYNGEAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCOREGIONALLY ADVANCED NASOPHARYNGEAL CARCINOMA trials appear
Sign up with your email to follow new studies for LOCOREGIONALLY ADVANCED NASOPHARYNGEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo tested to stop throat cancer return
Disease control Not yet recruitingThis study tests whether a new drug, Becotatug vedotin, works better than the standard drug capecitabine to prevent cancer from coming back in people with advanced nasopharyngeal carcinoma. About 218 adults who have already completed initial chemo-radiation will be randomly assig…
Matched conditions: LOCOREGIONALLY ADVANCED NASOPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: Kai Hu • Aim: Disease control
Last updated May 26, 2026 09:40 UTC
-
New drug duo aims to shrink throat cancer before standard therapy
Disease control Not yet recruitingThis study tests whether giving two drugs—pembrolizumab and MRG-003—before standard chemoradiation can improve outcomes for people with advanced nasopharyngeal cancer linked to the Epstein-Barr virus. About 35 adults with stage III-IVa disease will receive the combination, then s…
Matched conditions: LOCOREGIONALLY ADVANCED NASOPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated May 19, 2026 11:47 UTC